Tübingen has assumed the role of coordinating "Malaria" and "Antibiotic-resistant bacterial Infections". The main focus in Tübingen is on translating reserach results into medicine and vaccine development as well as on infection models and epidemiology. Regarding infections cuseb by antibiotic-resistant, bacterial pathogens, the focus is on multidrug-resistant pathogens such as methicillin-resistant staphylococci (MRSA) and multidrug-resistant gramnegative pathogens (e.g. so-called ESBLs). In 2016, the University of Tübingen established a first DZIF professorship in Africa, funded by the DZIF and the Government of Gabon. Other topics of importance to the Tübingen researchers are the search for new biomarkers for GI tract infections and agents against the responsible pathogens, and the search for and research into new anti-infective agents using novel methods and techniques, e.g. genome-mining and combinatorial biosynthesis.